CDK4 and breast cancer: Ongoing research and the development of new treatments, such as cyclin‐dependent kinase 4/6 inhibitors, poly ADP‐ribose polymerase inhibitors, and programmed death‐ligand 1 inhibitors, have greatly improved BC prognosis [25, 26].